Journal of Applied Physiology Millar Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 106: 1132-1141, 2009. First published February 12, 2009; doi:10.1152/japplphysiol.90542.2008
8750-7587/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/4/1132    most recent
90542.2008v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, F.
Right arrow Articles by Finkel, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, F.
Right arrow Articles by Finkel, M. S.

p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo

Fangping Chen,1 Hong Kan,1,2 Gerry Hobbs,4 and Mitchell S. Finkel1,2,3,5

Departments of 1Medicine, 2Physiology and Pharmacology, 3Psychiatry, and 4Statistics, West Virginia University, Morgantown; and 5Louis A. Johnson Department of Veterans Affairs Medical Center, Clarksburg, West Virginia

Submitted 18 April 2008 ; accepted in final form 9 February 2009

Recent clinical reports strongly support the intriguing possibility that emotional stress alone is sufficient to cause reversible myocardial dysfunction in patients. We previously reported that a combination of prenatal stress followed by restraint stress (PS+R) results in echocardiographic evidence of myocardial dysfunction in anesthetized rats compared with control rats subjected to the same restraint stress (Control+R). We now report results of our catheter-based hemodynamic studies in both anesthetized and freely ambulatory awake rats, comparing PS+R vs. Control+R. Systolic function [positive rate of change in left ventricular pressure over time (+dP/dt)] was significantly depressed (P < 0.01) in PS+R vs. Control+R both under anesthesia (6,287 ± 252 vs. 7,837 ± 453 mmHg/s) and awake (10,438 ± 741 vs. 12,111 ± 652 mmHg/s). Diastolic function (–dP/dt) was also significantly depressed (P < 0.05) in PS+R vs. Control+R both under anesthesia (–5,686 ± 340 vs. –7,058 ± 458 mmHg/s) and awake (–8,287 ± 444 vs. 10,440 ± 364 mmHg/s). PS+R also demonstrated a significantly attenuated (P < 0.05) hemodynamic response to increasing doses of the β-adrenergic agonist isoproterenol. Intraperitoneal injection of the p38 MAP kinase inhibitor SB-203580 reversed the baseline reduction in +dP/dt and –dP/dt as well as the blunted isoproterenol response. Intraperitoneal injection of SB-203580 also reversed p38 MAP kinase and troponin I phosphorylation in cardiac myocytes isolated from PS+R. Thus the combination of prenatal stress followed by restraint stress results in reversible depression in both systolic and diastolic function as well as defective β-adrenergic receptor signaling. Future studies in this animal model may provide insights into the basic mechanisms contributing to reversible myocardial dysfunction in patients with ischemic and nonischemic cardiomyopathies.

heart failure; emotional stress; hemodynamics



Address for reprint requests and other correspondence: M. S. Finkel, Dept. of Medicine, WVU Cardiology, Medical Center Dr., Morgantown, WV 26506-9157 (e-mail: mfinkel{at}hsc.wvu.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.